The Impact of Sugammadex on Ileus After Abdominal Wall Reconstruction

Inclusion Criteria: * Adults \>18 years old * Patients requiring an open ventral hernia repair with retromuscular mesh placement and at least one myofascial advancement flap * Hernias with fascial defects \< 20cm wide * Non-emergent cases Exclusion Criteria: * Known serious or severe hypersensitivity reaction to sugammadex or any of the ingredients in sugammadex. * Hernias with fascial defects \> 20cm wide * Concomitant treatment with a strong or moderate cytochrome P450 3A4 inhibitor (e.g., Ketoconazole and other anti-fungals, Clarithromycin, HIV protease inhibitors, diltiazem, erythromycin, verapamil) or strong CYP3A4 inducers (e.g., rifampin). * Known small bowel obstruction (SBO) at the time of hernia repair * Suspected SBO or at risk of recurrent SBO at the time of hernia repair - at the discretion of the staff surgeon. * Nasogastric (NG), orogastric (OG), or gastric (eg. PEG) in place at the time of hernia repair and left in beyond the morning of the first postoperative day. * Patients with a stoma. * Cancer with increased risk of gastro-duodenal perforation (e.g., infiltrative gastrointestinal tract malignancy, recent gastrointestinal tract surgery, diverticular disease including diverticulitis, ischemic colitis, or concomitantly treated with bevacizumab) - at the discretion of the staff surgeon. * Disorder that could alter the integrity of the gastrointestinal lining (e.g., Crohn's disease) - at the discretion of the staff surgeon. * Severe hepatic failure (Child-P…